Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Entrada Therapeutics, Inc. (TRDA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 31,211,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Entrada Therapeutics is an intracellular therapeutics company. Endosomal Escape Vehicle (EEV) therapeutics are comprised of small cyclic peptides that are chemically conjugated to a range of specific and active biological therapeutics. Co.'s EEV therapeutics are designed to engage intracellular targets that have long been considered inaccessible and undruggable. Through its proprietary modular EEV platform, Co. is building a development portfolio of EEV therapeutic candidates designed to enable the intracellular delivery of therapeutics in various organs and tissues with an improved therapeutic index. Co. is focused on the development of EEV therapeutics for rare neuromuscular diseases.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 20,368 20,368 20,368 181,768
Total Buy Value $277,268 $277,268 $277,268 $1,251,175
Total People Bought 1 1 1 2
Total Buy Transactions 10 10 10 18
Total Shares Sold 6,912 21,412 123,393 295,774
Total Sell Value $87,784 $313,620 $1,946,898 $4,759,691
Total People Sold 3 3 5 5
Total Sell Transactions 3 8 27 93
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 213
  Page 7 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Dowden Nathan J Chief Operating Officer   •       –      –    2022-09-01 4 A $0.00 $0 D/D 5,632 70,525     -
   Sethuraman Natarajan Chief Scientific Officer   •       –      –    2022-09-01 4 A $0.00 $0 D/D 5,794 162,144     -
   Kreher Nerissa Chief Medical Officer   •       –      –    2022-09-01 4 A $0.00 $0 D/D 5,172 20,716     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-09-01 4 A $0.00 $0 D/D 5,503 16,489     -
   Doshi Dipal President and CEO   •       •      –    2022-08-31 4 AS $12.00 $2,052 D/D (171) 206,710     -
   Doshi Dipal President and CEO   •       •      –    2022-08-30 4 AS $12.00 $2,280 D/D (190) 206,881     -
   Doshi Dipal President and CEO   •       •      –    2022-08-29 4 AS $12.56 $21,103 D/D (1,639) 207,071     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-08-25 4 AS $14.18 $21,986 D/D (1,551) 10,986     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-08-24 4 AS $13.52 $42,375 D/D (3,118) 12,537     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-08-24 4 OE $2.10 $2,346 D/D 1,117 15,655     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-08-23 4 AS $13.09 $38,080 D/D (2,909) 14,538     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-08-23 4 OE $2.10 $2,946 D/D 1,403 17,447     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-08-22 4 AS $13.00 $2,822 D/D (217) 16,044     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-08-22 4 OE $2.10 $246 D/D 117 16,261     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-08-19 4 AS $13.08 $111,530 D/D (8,529) 16,144     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-08-19 4 OE $2.10 $9,349 D/D 4,452 24,673     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-08-18 4 AS $13.00 $2,600 D/D (200) 20,221     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-08-18 4 OE $2.10 $210 D/D 100 20,441     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-08-17 4 AS $13.07 $2,614 D/D (200) 20,341     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-08-17 4 OE $2.10 $210 D/D 100 20,541     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-08-16 4 AS $13.00 $2,600 D/D (200) 20,441     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2022-08-16 4 OE $2.10 $210 D/D 100 20,641     -
   Doshi Dipal President and CEO   •       •      –    2022-07-27 4 AS $12.00 $24,000 D/D (2,000) 208,710     -
   Doshi Dipal President and CEO   •       •      –    2022-06-27 4 AS $12.00 $48,000 D/D (4,000) 210,710     -
   Dowden Nathan J Chief Operating Officer   •       –      –    2022-06-27 4 AS $13.00 $100,282 D/D (7,714) 64,893     -
  213 Records found
  1  2  3  4  5  6  7  8  9   
  Page 7 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us